Lv4
630 积分 2021-06-24 加入
Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors
3天前
已完结
CNSC-31. INVESTIGATING THE THERAPEUTIC POTENTIAL OF STK17A INHIBITION IN GLIOBLASTOMA
3天前
求助中
Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
10天前
已完结
148 (PB136): UMF814A is a potent, selective and orally bioavailable STK17A inhibitor for MDS/AML
13天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
14天前
已完结
Discovery and evaluation of HW161023 as a potent and orally active AAK1 inhibitor
20天前
已完结
Core Modifications of GSK3335103 toward Orally Bioavailable αvβ6 Inhibitors with Improved Synthetic Tractability
1个月前
已完结
WITHDRAWN: ActRIIB small molecule inhibitor 2-67 ameliorates muscle atrophy in cancer cachexia by inhibiting the myostatin/Smad pathway
1个月前
已完结
Blockade of ActRIIB Signaling Triggers Muscle Fatigability and Metabolic Myopathy
1个月前
已完结
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
1个月前
已完结
皖公网安备34019202002308
